Caption Management’s Novo Nordisk NVO Stock Holding History

Caption Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.23M	Sell	60,600 -19,571	-24%	-$927K	0.01%	794
2025 Q4	$4.08M	Buy	+80,171	New	+$4.1M	0.03%	581
2025 Q1	–	Sell	-101,750	Closed	-$8.4M	–	1882
2024 Q4	$8.75M	Buy	101,750 +88,355	+660%	+$9.55M	0.08%	226
2024 Q3	$1.59M	Buy	+13,395	New	+$1.79M	0.03%	641
2023 Q4	–	Sell	-25,000	Closed	-$2.47M	–	1558
2023 Q3	$2.27M	Buy	+25,000	New	+$2.2M	0.04%	543
2022 Q3	–	Sell	-1,200	Closed	-$67K	–	1752
2022 Q2	$67K	Buy	+1,200	New	+$66.6K	﹤0.01%	1323
2021 Q3	–	Sell	-40,000	Closed	-$1.68M	–	1702
2021 Q2	$1.68M	Buy	+40,000	New	+$1.55M	0.02%	744
2018 Q4	–	Sell	-26,800	Closed	-$632K	–	568
2018 Q3	$632K	Buy	+26,800	New	+$654K	0.03%	391

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Caption Management's NVO Position: Q1 2026 in Review

Caption Management reduced its Novo Nordisk (NVO) stake by 24% in Q1 2026, selling an estimated $927K and leaving 60,600 shares worth $2.23M. The position accounts for 0.01% of the portfolio, ranked #794.

Caption Management first reported a position in NVO in Q3 2018 and has held it in 8 quarters since. The position peaked at $8.75M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Caption Management held 60,600 shares of Novo Nordisk worth $2.23M as of Q1 2026.
Caption Management sold 19,571 Novo Nordisk shares in Q1 2026, an estimated $927K.
Novo Nordisk made up 0.01% of Caption Management's portfolio in Q1 2026, its #794 holding.
Caption Management first reported a position in Novo Nordisk in Q3 2018 and has held it in 8 quarters since.
Caption Management's Novo Nordisk position peaked at $8.75M in Q4 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.